These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prolonged growth of infantile hemangioma after pulsed dye laser and oral propranolol treatment. Kagami S; Kaneko M; Kishi A; Katori T J Dermatol; 2018 Sep; 45(9):1109-1112. PubMed ID: 29952019 [TBL] [Abstract][Full Text] [Related]
6. Propranolol therapy for infantile hemangioma: our experience. Zhang L; Wu HW; Yuan W; Zheng JW Drug Des Devel Ther; 2017; 11():1401-1408. PubMed ID: 28507428 [TBL] [Abstract][Full Text] [Related]
7. Propranolol versus corticosteroids: what should be the treatment of choice in infantile hemangiomas? Theunissen CI; Smitt JH; van der Horst CM Ann Plast Surg; 2015 Feb; 74(2):237-41. PubMed ID: 24051459 [TBL] [Abstract][Full Text] [Related]
8. Infantile hemangioma. Part 2: Management. Sebaratnam DF; Rodríguez Bandera AL; Wong LF; Wargon O J Am Acad Dermatol; 2021 Dec; 85(6):1395-1404. PubMed ID: 34419523 [TBL] [Abstract][Full Text] [Related]
9. Residual Lesions After Pharmacological and Dye-Laser Treatment of Infantile Hemangiomas: Critical Review of 432 Cases. Chelleri C; Monzani NA; Gelmetti C; Milani GP; Fossali EF; Galeone C; Cavalli R Lasers Surg Med; 2020 Sep; 52(7):597-603. PubMed ID: 31828809 [TBL] [Abstract][Full Text] [Related]
10. Persistent dysesthesias in involuted infantile hemangiomas: An uncommon complication in a common condition. Braun M; Metry D; Frieden IJ; Antaya RJ; Mancini AJ; Kohn LL Pediatr Dermatol; 2021 Sep; 38(5):1061-1065. PubMed ID: 34339535 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas. Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885 [TBL] [Abstract][Full Text] [Related]
12. Infantile hemangiomas: an update. Kwon EK; Seefeldt M; Drolet BA Am J Clin Dermatol; 2013 Apr; 14(2):111-23. PubMed ID: 23338947 [TBL] [Abstract][Full Text] [Related]
14. Morphological, genetic and clinical correlations in infantile hemangiomas and their mimics. Luca AC; Miron IC; Trandafir LM; Cojocaru E; Pădureţ IA; Trandafirescu MF; Iordache AC; Ţarcă E Rom J Morphol Embryol; 2020; 61(3):687-695. PubMed ID: 33817710 [TBL] [Abstract][Full Text] [Related]
15. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines. Kumar MG; Coughlin C; Bayliss SJ Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828 [TBL] [Abstract][Full Text] [Related]
16. [Infantile hemangiomas: the revolution of beta-blockers]. Leaute-Labreze C Rev Prat; 2014 Dec; 64(10):1421-8. PubMed ID: 25665327 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521 [TBL] [Abstract][Full Text] [Related]